Approved vaccination with third dose of Pfizer mRNA SARS-coV2 vaccine to adolescentsvaged 12 to 17 years; Immunocompromised persons who have received CoronaVac + CoronaVac Pfizer_BioNtech + Pfizer-BioNtech: Fifth dose of Pfizer mRNA platform vaccine to 6 months after last dose; Immunocompromised

The immunization technical standard is in the process of being updated; Evidence and epidemiological data are being compiled to determine the inclusion of the Hepatitis A and meningococcal vaccine.